ROBIN HOGLUND: Open Payments
NPI 1700627924 · LOGAN, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$318 in 15 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $207 · 2025 $318
Food & beverage: $318
| Company | Payments | Amount |
|---|---|---|
| Travere Therapeutics, Inc. | 7 | $167 |
| Calliditas Therapeutics US Inc. | 4 | $65 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $25 |
| Amgen Inc. | 1 | $23 |
| ANI Pharmaceuticals, Inc. | 1 | $20 |
| GlaxoSmithKline, LLC. | 1 | $19 |
Products named: TARPEYO, Kerendia, TAVNEOS, PURIFIED CORTROPHIN GEL, BENLYSTA.
Industry payments across UT — which companies pay providers there.
